Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
495
2.510
 Why?
Thrombolytic Therapy
4
2022
110
1.230
 Why?
Pneumonia, Viral
6
2020
169
1.230
 Why?
Fibrinolytic Agents
4
2022
125
1.220
 Why?
Coronavirus Infections
6
2020
176
1.210
 Why?
Tissue Plasminogen Activator
3
2020
110
1.190
 Why?
Pandemics
8
2020
553
0.800
 Why?
Endovascular Procedures
2
2022
180
0.790
 Why?
Cavernous Sinus
1
2022
16
0.760
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
12
0.760
 Why?
Embolization, Therapeutic
1
2022
87
0.700
 Why?
Conflict of Interest
2
2020
25
0.700
 Why?
Iodine Compounds
1
2020
7
0.680
 Why?
Brain Edema
1
2020
38
0.660
 Why?
Brain Ischemia
4
2022
163
0.620
 Why?
Contrast Media
1
2020
191
0.610
 Why?
Mucopolysaccharidosis II
1
2018
1
0.610
 Why?
Cardiology
1
2020
91
0.610
 Why?
Medicare
1
2020
247
0.600
 Why?
Coronary Angiography
1
2020
360
0.590
 Why?
Physicians
1
2020
235
0.540
 Why?
Hospitalization
6
2022
677
0.470
 Why?
Databases, Factual
3
2020
676
0.410
 Why?
Humans
29
2022
50419
0.400
 Why?
Telemedicine
1
2019
468
0.400
 Why?
Headache
2
2022
74
0.350
 Why?
Aged
10
2021
9738
0.350
 Why?
Time Factors
4
2020
2933
0.340
 Why?
Autoimmune Diseases
2
2020
78
0.330
 Why?
Ischemic Attack, Transient
2
2020
56
0.320
 Why?
Immunosuppressive Agents
2
2020
227
0.310
 Why?
United States
6
2020
5005
0.290
 Why?
Female
16
2021
27053
0.280
 Why?
Male
14
2021
25866
0.260
 Why?
Arkansas
4
2019
1974
0.260
 Why?
Emergency Service, Hospital
2
2020
489
0.250
 Why?
Middle Aged
11
2021
12579
0.240
 Why?
Tomography, X-Ray Computed
2
2020
1163
0.220
 Why?
Triage
2
2021
60
0.210
 Why?
Thrombectomy
2
2020
72
0.210
 Why?
Drug Industry
2
2020
38
0.210
 Why?
Neuroimaging
2
2020
86
0.200
 Why?
Critical Care
2
2021
214
0.190
 Why?
Retrospective Studies
5
2020
6274
0.190
 Why?
Sinus Thrombosis, Intracranial
1
2021
16
0.180
 Why?
Myasthenia Gravis
1
2021
17
0.180
 Why?
Hospitalists
1
2020
11
0.180
 Why?
Intracranial Thrombosis
1
2020
16
0.180
 Why?
Ageusia
1
2020
6
0.170
 Why?
Olfaction Disorders
1
2020
7
0.170
 Why?
Neuromuscular Diseases
1
2020
30
0.170
 Why?
Osmolar Concentration
1
2020
62
0.170
 Why?
Health Services Misuse
1
2020
13
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2020
55
0.170
 Why?
Multiple Sclerosis
1
2020
64
0.170
 Why?
Health Care Sector
1
2020
15
0.170
 Why?
Neurologic Examination
1
2020
75
0.170
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.170
 Why?
Mood Disorders
1
2020
58
0.170
 Why?
Time-to-Treatment
1
2020
73
0.160
 Why?
Patient Transfer
1
2020
95
0.160
 Why?
Young Adult
2
2020
4075
0.160
 Why?
Venous Thrombosis
1
2020
86
0.160
 Why?
Brain Diseases
1
2020
83
0.160
 Why?
Drug-Eluting Stents
1
2020
93
0.160
 Why?
Suicidal Ideation
1
2020
96
0.160
 Why?
Subarachnoid Hemorrhage
1
2020
65
0.160
 Why?
Recombinant Fusion Proteins
1
2010
186
0.160
 Why?
Fabry Disease
1
2019
9
0.160
 Why?
Enzyme Replacement Therapy
1
2019
17
0.160
 Why?
Hospitals
1
2020
170
0.160
 Why?
Nervous System Diseases
1
2020
89
0.160
 Why?
Fluorocarbons
1
2019
58
0.150
 Why?
Tomography Scanners, X-Ray Computed
1
2018
12
0.150
 Why?
Angiogenesis Inhibitors
1
2010
183
0.150
 Why?
Aged, 80 and over
3
2020
3233
0.150
 Why?
Angiography, Digital Subtraction
1
2018
27
0.150
 Why?
Neuroprotective Agents
1
2019
97
0.150
 Why?
Seizures
1
2020
198
0.150
 Why?
Anxiety
1
2020
285
0.140
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
136
0.140
 Why?
Pain
1
2020
386
0.140
 Why?
Meningitis
1
2016
25
0.130
 Why?
Referral and Consultation
1
2019
287
0.130
 Why?
Diagnosis, Differential
1
2020
1029
0.130
 Why?
Myocardial Infarction
1
2020
402
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
300
0.130
 Why?
Antibodies, Monoclonal
1
2010
460
0.130
 Why?
Ovarian Neoplasms
1
2010
449
0.120
 Why?
Plasma Cells
1
2016
220
0.120
 Why?
Magnetic Resonance Imaging
2
2020
1546
0.120
 Why?
Adult
5
2020
13561
0.110
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
33
0.100
 Why?
DNA, Complementary
1
2002
134
0.100
 Why?
Adolescent
2
2020
6453
0.100
 Why?
Antineoplastic Agents
1
2010
1165
0.090
 Why?
Mycobacterium tuberculosis
1
2002
266
0.090
 Why?
Treatment Outcome
4
2022
5265
0.080
 Why?
Intubation, Intratracheal
2
2021
119
0.080
 Why?
Cohort Studies
2
2022
1451
0.070
 Why?
Prevalence
2
2020
967
0.070
 Why?
Risk Factors
2
2022
3712
0.050
 Why?
Intracranial Hemorrhages
1
2022
38
0.050
 Why?
Multiple Myeloma
1
2016
2990
0.050
 Why?
Cerebral Hemorrhage
1
2022
100
0.050
 Why?
Cranial Sinuses
1
2021
10
0.050
 Why?
Industry
1
2020
17
0.040
 Why?
Arthritis, Psoriatic
1
2020
9
0.040
 Why?
Spondylitis, Ankylosing
1
2020
9
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
87
0.040
 Why?
Endocrine System Diseases
1
2010
10
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
 Why?
Mortality
1
2020
96
0.040
 Why?
Colitis, Ulcerative
1
2020
55
0.040
 Why?
Arthritis, Rheumatoid
1
2020
108
0.040
 Why?
Crohn Disease
1
2020
93
0.040
 Why?
Maximum Tolerated Dose
1
2019
39
0.040
 Why?
Administration, Oral
1
2020
438
0.040
 Why?
Disease Outbreaks
1
2020
118
0.040
 Why?
Tertiary Care Centers
1
2019
78
0.040
 Why?
Registries
1
2022
565
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
70
0.040
 Why?
Hemorrhage
1
2020
195
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Gastrointestinal Diseases
1
2010
124
0.040
 Why?
Skin Diseases
1
2010
126
0.040
 Why?
Electronic Health Records
1
2021
222
0.040
 Why?
Drug Administration Schedule
1
2019
373
0.040
 Why?
Recovery of Function
1
2019
191
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
224
0.040
 Why?
Comorbidity
1
2019
621
0.040
 Why?
Patient Readmission
1
2019
229
0.040
 Why?
Double-Blind Method
1
2019
710
0.040
 Why?
Prognosis
1
2022
1974
0.030
 Why?
Fatal Outcome
1
2016
197
0.030
 Why?
Follow-Up Studies
1
2020
2231
0.030
 Why?
Risk Assessment
1
2019
1268
0.030
 Why?
Cardiovascular Diseases
1
2010
464
0.030
 Why?
Prospective Studies
1
2020
2378
0.030
 Why?
Cross-Sectional Studies
1
2019
1601
0.030
 Why?
DNA Primers
1
2002
205
0.020
 Why?
Infant
1
2020
3648
0.020
 Why?
Child, Preschool
1
2020
3953
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
400
0.020
 Why?
Transcription, Genetic
1
2002
354
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
180
0.020
 Why?
RNA, Messenger
1
2002
1085
0.020
 Why?
Child
1
2020
6931
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (151) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department